A Case-Report on the Presentation of Pulmonary Langerhans Cell Histiocytosis

Authors

  • Vivek Gautam, MD The Wright Center for GME, Scranton, PA
  • Justin Shen A.T. Still University School of Osteopathic Medicine, Mesa, AZ
  • Simin Nasr, MD The Wright Center for GME, Scranton, PA

Keywords:

Pulmonary Langerhans cell histiocytosis, Granulomas, Lung transplantation

Abstract

Pulmonary Langerhans Cell Histiocytosis (PLCH) is a rare disorder of the lungs characterized by the accumulation of CD1a+ cells in loosely formed granulomas in small airways. A patient with PLCH commonly presents with a smoking history with peak onset between 20 to 40 years of age. PLCH outcomes show a shorter survival rate than the general population and require lung transplantation for survival. In this report, we describe a 42-year-old Caucasian female who presents with a unique episode of bilateral spontaneous pneumothorax and shortness of breath. Pathological samples of the pulmonary biopsy showed Langerhans cells stained positive for CD1a and S100, consistent with the diagnosis for PLCH. The patient was further counseled on smoking cessation with eventual symptom improvement.

References

Vassallo, R., et al. “Current understanding and management of pulmonary Langerhans cell histiocytosis”. Thorax. 72(2017):937-945.

Tazi, A. “Adult pulmonary Langerhans’ cell histiocytosis”. Eur Respir J. 27(2006):1272-1285.

Vassallo, R., et al. “Clinical outcomes of pulmonary Langerhans’-cell histiocytosis in adults”. N Engl J Med. 346(2002):484-490.

Radzikowska, E. “Update on pulmonary langerhans cell histiocytosis”. Front Med. 7(2020):582581.

Castoldi, MC., et al. “Pulmonary Langerhans cell histiocytosis: The many faces of presentation at initial CT scan”. Insights Imaging. 5(2014):483- 492.

Wei, P., et al. “Pulmonary langerhans cell histiocytosis: Case series and literature review”. Medicine. 93(2014):e141.

Mendez, JL., et al. “Pneumothorax in pulmonary Langerhans cell histiocytosis”. Chest. (125)2004:1028-1032.

Nakhla, H., et al. “Sudden death of a patient with pulmonary Langerhans cell histiocytosis”. Arch Pathol Lab Med. 129(2005):798-799.

Girschikofsky, M., et al. “Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net”. Orphanet J Rare Dis. 8(2013):72.

Casolaro, MA., et al. “Accumulation of langerhans’ cells on the epithelial surface of the lower respiratory tract in normal subjects in association with cigarette smoking”. Am Rev Respir Dis. 137(1988):406-411.

Lorillon, G., et al. “How I manage pulmonary Langerhans cell histiocytosis”. Eur Respir Rev. 26(2017).

Grobost, V., et al. “Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis”. Orphanet J Rare Dis. 9(2014):191.

Hyman, DM., et al. “Vemurafenib in multiple nonmelanoma cancers with BRAFV600 mutations”. N Engl J Med. 373(2015):726-736.

Downloads

Published

2024-06-30

How to Cite

Gautam, V., Shen, J., & Nasr, S. (2024). A Case-Report on the Presentation of Pulmonary Langerhans Cell Histiocytosis. The Scholarly Society of America, 3(1), 34–37. Retrieved from http://ssajm-online.org/ojs/index.php/SSAJM/article/view/20

Issue

Vol. 3 (2024): Issue 1

Section

Case Reports

License

Copyright (c) 2024 The Scholarly Society of America

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)